Jul. 27, 2022
TAS1553
oral RNR subunit interaction inhibitor Ph. I candidate in oncology HTS and SBDD Commun. Biol. Taiho Pharmaceutical Co., Ltd., Tsukuba, JP
oral RNR subunit interaction inhibitor Ph. I candidate in oncology HTS and SBDD Commun. Biol. Taiho Pharmaceutical Co., Ltd., Tsukuba, JP